Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR2 | P30518 | 1/20 | 0.39 |
| ▸ | OXTR | P30559 | 1/20 | 0.39 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.39 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.37 |
| ▸ | EIF2AK3 | Q9NZJ5 | 1/20 | 0.36 |
| ▸ | GCK | P35557 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | NAMPT | P43490 | 4/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Padoprazan SCHEMBL30250197 | 1.00 | AVPR2 (0.39) | AVPR2OXTRAVPR1AEPHB4EIF2AK3 | |
| Padoprazan SCHEMBL30985953 | 0.93 | AVPR2 (0.36) | AVPR2OXTRAVPR1AEPHB4EIF2AK3 | |
| SCHEMBL30250036 | 0.91 | SLC6A2 (0.35) | MEN1KMT2ATSHRSMN1; SMN2HTT | |
| SCHEMBL28996377 | 0.91 | SLC6A2 (0.35) | MEN1KMT2ATSHRSMN1; SMN2HTT | |
| SCHEMBL26650833 | 0.89 | MEN1 (0.37) | OXTRAVPR1AEIF2AK3GCKMEN1 | |
| SCHEMBL30250130 | 0.89 | MEN1 (0.37) | OXTRAVPR1AEIF2AK3GCKMEN1 | |
| SCHEMBL30427346 | 0.83 | MEN1 (0.36) | OXTRAVPR1AMEN1KMT2APABPC1 | |
| SCHEMBL30287347 | 0.82 | KMT2A (0.41) | AVPR2OXTRAVPR1AEPHB4EIF2AK3 | |
| SCHEMBL25228488 | 0.82 | KMT2A (0.41) | AVPR2OXTRAVPR1AEPHB4EIF2AK3 | |
| SCHEMBL29241023 | 0.82 | KAT6A (0.34) | PTGS1PTGS2HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250084026-A1 | NOVEL SALT OF 1-SULFONYL PYRROLE DERIVATIVE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF | ILDONG PHARMACEUTICAL CO LTD (KR) | 2025-03-13 | — | — | US | claimed |
| US-20250042872-A1 | NOVEL SALT OF 1-SULFONYL PYRROLE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2025-02-06 | — | — | US | claimed |
| CN-115884968-B | Novel acid secretion inhibitor and use thereof | 日东制药株式会社 | 2024-06-21 | — | — | CN | claimed |
| US-20230373954-A1 | NOVEL ACID SECRETION INHIBITOR AND USE THEREOF | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2023-11-23 | — | — | US | claimed |
| WO-2023113458-A1 | NOVEL SALT OF 1-SULFONYL PYRROLE DERIVATIVE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2023-06-22 | — | — | WO | claimed |
| CN-115884968-A | Novel acid secretion inhibitor and use thereof | 日东制药株式会社 | 2023-03-31 | — | — | CN | claimed |
| US-20250084026-A1 | NOVEL SALT OF 1-SULFONYL PYRROLE DERIVATIVE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF | ILDONG PHARMACEUTICAL CO LTD (KR) | 2025-03-13 | — | — | US | disclosed |
| US-20250042872-A1 | NOVEL SALT OF 1-SULFONYL PYRROLE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2025-02-06 | — | — | US | disclosed |
| CN-115884968-B | Novel acid secretion inhibitor and use thereof | 日东制药株式会社 | 2024-06-21 | — | — | CN | disclosed |
| WO-2023229322-A1 | METHOD FOR PREPARING 6-METHOXYPYRIDIN-3-YL DERIVATIVES | 일동제약(주) | 2023-11-30 | — | — | WO | disclosed |
| US-11767311-B2 | Acid secretion inhibitor and use thereof | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2023-09-26 | — | — | US | disclosed |
| US-20230192650-A1 | NOVEL ACID SECRETION INHIBITOR AND USE THEREOF | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| WO-2023113458-A1 | NOVEL SALT OF 1-SULFONYL PYRROLE DERIVATIVE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023113474-A1 | NOVEL SALT OF 1-SULFONYL PYRROLE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | 일동제약(주) | 2023-06-22 | — | — | WO | disclosed |
| CN-115884968-A | Novel acid secretion inhibitor and use thereof | 日东制药株式会社 | 2023-03-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11767311-B2 | Acid secretion inhibitor and use thereof | SLC10A2, SLC10A1, ASIC1 | AVPR2 34/4885OXTR 3336/4885AVPR1A 527/4885 |
| US-20250084026-A1 | NOVEL SALT OF 1-SULFONYL PYRROLE DERIVATIVE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF | ABCG2, SLC7A1, SLC34A1 | AVPR2 303/4885OXTR 3536/4885AVPR1A 407/4885 |
| US-20250042872-A1 | NOVEL SALT OF 1-SULFONYL PYRROLE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | SRM, SLC7A1, SLC20A1 | AVPR2 557/4885OXTR 3456/4885AVPR1A 686/4885 |
| US-20230373954-A1 | NOVEL ACID SECRETION INHIBITOR AND USE THEREOF | SLC10A2, SLC10A1, ASIC1 | AVPR2 41/4885OXTR 3292/4885AVPR1A 618/4885 |
| US-20230192650-A1 | NOVEL ACID SECRETION INHIBITOR AND USE THEREOF | SLC10A2, SLC10A1, ASIC1 | AVPR2 41/4885OXTR 3292/4885AVPR1A 618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.